Does NT-proBNP assay help in the clinical assessment of dogs with respiratory signs?
The purpose of this study is to determine the accuracy of veterinarians in diagnosing congestive heart failure (CHF) or primary pulmonary disease as the etiology of respiratory signs in dogs. Our hypothesis is that NT-proBNP assay will help improve accuracy of diagnosis and veterinarian confidence when used in conjunction with traditional diagnostics such as ECG and thoracic radiography. The survey contains actual case data from 10 dogs that presented for for evaluation of respiratory signs to one of two veterinary referral centers (University of Pennsylvania and Tufts University). For each case, you will be presented with signalment, history, physical exam findings, bloodwork, chest radiographs, and an ECG. Based on these diagnostic tests, you will be then asked to make a diagnosis of CHF or primary respiratory disease. You will also have a chance to express your level of confidence in your particular diagnosis on a scale of 1-10. Following this, you will be presented with the results
Related Questions
- Can clinical symptoms or signs accurately predict hypoxemia in children with acute lower respiratory tract infections?
- Can assessment for obstructive sleep apnea help predict postadenotonsillectomy respiratory complications?
- Why dont you do MSN 538 Advanced Health Assessment and the clinical during the summer?
